Company intelligence / Profile preview

NanoSpeed Diagnostics

Edmonton, Alberta, Canada

Ownership: Private
Development stage: Other

Overview

NanoSpeed has commercialized rapid Vitamin D tests using a single drop of blood with results within minutes. The company is currently developing an AI-assisted diagnostic platform that analyzes blood samples using spectrometry and microscopy, enabling multiple assessments from a single drop without destructive wet chemistry reactions.

Therapeutic areas: OncologyEndocrinologyNeurology
Modalities: Device
Industry: Metabolite Diagnostics

Partnerships

Western Economic Diversification Canada Regional Innovation Ecosystems program (collaborative partners in non-profit, business, and academia sectors)

Beyond the preview

Go deeper on NanoSpeed Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NanoSpeed Diagnostics.

Explore the full profile